USA: Sartorius Opens New Bioanalytical Testing Laboratory Cutting-Edge Bioanalysis

Editor: Alexander Stark

Sartorius Stedim Biotech opened a new bioanalytical and biosafety testing laboratory in Boston.

Related Company

SSB’s new laboratory will provide GMP-compliant in vitro and PCR-based assays for the detection of adventitious agents.
SSB’s new laboratory will provide GMP-compliant in vitro and PCR-based assays for the detection of adventitious agents.
(Source: Startorius)

Goettingen/Germany — The bioanalytical laboratory will produce the company's Bio Outsource brand of products and the associated services for North American customers. At the opening ceremony, Reinhardt Vogt, member of SSB’s Executive Committee, stated: “Our new laboratory will offer customers the analytical expertise to help them accelerate entry into clinical phases. We chose Boston as the site for our laboratory because it is a premier biotech hub, enabling us to showcase our portfolio of bioanalytical and biosafety tests, as well as attract the best technical staff to continue our expansion here in the future.”

The new laboratory features cutting edge technology, such as biacore analytical instruments, and offers advanced analysis services such as Antibody Dependent Cell Cytotoxicity (ADCC); Complement Dependent Cytotoxicity (CDC) and Surface Plasmon Resonance (SPR) assay platforms; as well as cell-based assays and enzyme-linked immunosorbent assays (ELISAs). SSB’s new laboratory, which covers approximately 9,000 square feet (830 m2), will also provide GMP-compliant in vitro and PCR-based assays for the detection of adventitious agents.

(ID:44373780)